Mumps virus strain B level jeryl lynn live antigen
This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.
Identification
- Name
- Mumps virus strain B level jeryl lynn live antigen
- Accession Number
- DB10316
- Description
Mumps virus strain B level jeryl lynn live antigen is a live attenuated virus vaccine for subcutenous injection. It is an active immunization against mumps, which is a common childhood disease.
- Type
- Biotech
- Groups
- Approved, Investigational
- Biologic Classification
- Vaccines
Attenuated - Synonyms
- Mumps Virus Vaccine Live, Jeryl Lynn Strain
Pharmacology
- Indication
- Not Available
- Associated Conditions
- Contraindications & Blackbox Warnings
Learn about our commercial Contraindications & Blackbox Warnings data.
Learn More- Pharmacodynamics
- Not Available
- Mechanism of action
- Not Available
- Absorption
- Not Available
- Volume of distribution
- Not Available
- Protein binding
- Not Available
- Metabolism
- Not Available
- Route of elimination
- Not Available
- Half-life
- Not Available
- Clearance
- Not Available
- Adverse Effects
Learn about our commercial Adverse Effects data.
Learn More- Toxicity
- Not Available
- Affected organisms
- Not Available
- Pathways
- Not Available
- Pharmacogenomic Effects/ADRs
- Not Available
Interactions
- Drug Interactions
- This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.Not Available
- Food Interactions
- Not Available
Products
- Mixture Products
Name Ingredients Dosage Route Labeller Marketing Start Marketing End Region Image M-M-R II Mumps virus strain B level jeryl lynn live antigen (12500 TCID50/0.5mL) + Measles virus vaccine live attenuated (1000 TCID50/0.5mL) + Rubella virus vaccine (1000 TCID50/0.5mL) Powder, for solution Subcutaneous Merck Ltd. 1979-12-31 Not applicable Canada 
M-M-R II Mumps virus strain B level jeryl lynn live antigen (12500 [TCID_50]/0.5mL) + Measles virus vaccine live attenuated (1000 [TCID_50]/0.5mL) + Rubella virus vaccine (1000 [TCID_50]/0.5mL) Injection, powder, lyophilized, for suspension Subcutaneous A-S Medication Solutions 1971-04-21 Not applicable US 
M-M-R II Mumps virus strain B level jeryl lynn live antigen (12500 [TCID_50]/0.5mL) + Measles virus vaccine live attenuated (1000 [TCID_50]/0.5mL) + Rubella virus vaccine (1000 [TCID_50]/0.5mL) Injection, powder, lyophilized, for suspension Subcutaneous Physicians Total Care, Inc. 1996-08-07 2012-06-30 US M-M-R II Mumps virus strain B level jeryl lynn live antigen (12500 [TCID_50]/0.5mL) + Measles virus vaccine live attenuated (1000 [TCID_50]/0.5mL) + Rubella virus vaccine (1000 [TCID_50]/0.5mL) Injection, powder, lyophilized, for suspension Subcutaneous Merck Sharp & Dohme Corp. 1971-04-21 Not applicable US Priorix Mumps virus strain B level jeryl lynn live antigen (103.7 CCID50/0.5mL) + Measles virus vaccine live attenuated (103.0 CCID50/0.5mL) + Rubella virus vaccine (103.0 CCID50/0.5mL) Kit; Powder, for solution Intramuscular; Subcutaneous Glaxosmithkline Inc 1998-12-04 Not applicable Canada ProQuad Mumps virus strain B level jeryl lynn live antigen (20000 [TCID_50]/0.5mL) + Measles virus vaccine live attenuated (1000 [TCID_50]/0.5mL) + Rubella virus vaccine (1000 [TCID_50]/0.5mL) + Varicella Zoster Vaccine (Live/attenuated) (9772 [PFU]/0.5mL) Injection, powder, lyophilized, for suspension Subcutaneous Merck Sharp & Dohme Corp. 2015-07-01 Not applicable US ProQuad Mumps virus strain B level jeryl lynn live antigen (20000 [TCID_50]/0.5mL) + Measles virus vaccine live attenuated (1000 [TCID_50]/0.5mL) + Rubella virus vaccine (1000 [TCID_50]/0.5mL) + Varicella Zoster Vaccine (Live/attenuated) (9772 [PFU]/0.5mL) Injection, powder, lyophilized, for suspension Subcutaneous Merck Sharp & Dohme Limited 2005-09-06 2018-08-31 US ProQuad Mumps virus strain B level jeryl lynn live antigen (4.3 log10 tcid50/0.5mL) + Measles virus vaccine live attenuated (3 log10 tcid50/0.5mL) + Rubella virus vaccine (3 log10 tcid50/0.5mL) + Varicella Zoster Vaccine (Live/attenuated) (3.99 log10 tcid50/0.5mL) Powder, for solution Subcutaneous Merck Ltd. 2014-05-09 Not applicable Canada
Categories
- Drug Categories
- Classification
- Not classified
Chemical Identifiers
- UNII
- 47QB6MX9KU
- CAS number
- Not Available
References
Clinical Trials
- Clinical Trials
Phase Status Purpose Conditions Count 4 Completed Prevention BCG Infection / Immune Response / Reaction - Vaccine 1 4 Completed Prevention Chickenpox / Hepatitis A / Mumps / Rubella / Rubeola 1 4 Completed Prevention Encephalitis, Japanese B / Mumps / Rubella / Rubeola 1 4 Completed Prevention Hepatitis A Virus 1 4 Completed Prevention Mumps / Rubella / Rubeola 2 3 Completed Prevention Acellular Pertussis / Diphtheria / Poliomyelitis / Tetanus 1 3 Completed Prevention Acellular Pertussis / Diphtheria / Tetanus 1 3 Completed Prevention Bacterial Infections / Neisseria Meningitidis / Virus Diseases 2 3 Completed Prevention Bacterial Infections / Virus Diseases 1 3 Completed Prevention Chickenpox Vaccines / Varicella 1
Pharmacoeconomics
- Manufacturers
- Not Available
- Packagers
- Not Available
- Dosage Forms
Form Route Strength Injection, powder, lyophilized, for solution Subcutaneous 1000 [CCID_50]/0.5mL Injection, powder, lyophilized, for suspension Subcutaneous Injection, powder, for suspension Intramuscular; Subcutaneous 1000 CCID50/0.5mL Injection, powder, lyophilized, for solution Intramuscular; Subcutaneous 1000 TCID Injection, powder, lyophilized, for suspension Subcutaneous 1000 [TCID_50]/0.5mL Injection, powder, for solution Intramuscular; Subcutaneous 103 CCID50/0.5mL Injection, powder, for solution Subcutaneous 103 CCID50/0.5mL Kit; powder, for solution Intramuscular; Subcutaneous Injection, solution Intramuscular; Subcutaneous 1000 CCID Injection, powder, for solution Intramuscular; Subcutaneous 1000 CCID Injection, powder, lyophilized, for solution Intramuscular; Subcutaneous 10 CCID Injection, solution Intramuscular; Subcutaneous 5011 CCID50/0.5mL Injection, powder, for solution Intramuscular; Subcutaneous 5011 CCID50/0.5mL Injection, powder, for solution Subcutaneous 10 CCID Injection, powder, lyophilized, for suspension Subcutaneous 1000 CCID_50 Injection, powder, lyophilized, for solution Subcutaneous 10 CCID Injection, powder, for suspension Intramuscular; Subcutaneous 1000 [TCID_50]/0.5mL Injection, powder, lyophilized, for suspension Intramuscular; Subcutaneous 1000 [TCID_50]/0.5mL Powder, for solution Subcutaneous Injection, powder, lyophilized, for suspension Intramuscular; Subcutaneous 3 log10/0.5ml Injection Subcutaneous 1000 CCID50/0.5mL - Prices
- Not Available
- Patents
- Not Available
Properties
- State
- Not Available
- Experimental Properties
- Not Available
Drug created on December 01, 2015 13:03 / Updated on June 12, 2020 10:53
Improve the accuracy of your
Precision Medicine software.
DrugBank's structured data is collected, curated and updated daily by our team of pharmacists, pharmacologists and medical doctors. Learn More.